The global Respiratory Syncytial Virus Diagnostic Testing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Antigen Detection Test Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Respiratory Syncytial Virus Diagnostic Testing include F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc. and Cepheid (Danaher Corporation), etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and breathing passages). It is a common cause of upper and lower respiratory infections in infants, young children, and elderly people. The infection can lead to severe complications such as pneumonia and bronchiolitis.
This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Diagnostic Testing. This report contains market size and forecasts of Respiratory Syncytial Virus Diagnostic Testing in global, including the following market information:
Global Respiratory Syncytial Virus Diagnostic Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Respiratory Syncytial Virus Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Syncytial Virus Diagnostic Testing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Respiratory Syncytial Virus Diagnostic Testing Market Segment Percentages, by Type, 2023 (%)
Antigen Detection Test
Molecular Diagnostic Test
Direct Fluorescent Antibody Test
Diagnostic Imaging
Others
Global Respiratory Syncytial Virus Diagnostic Testing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Respiratory Syncytial Virus Diagnostic Testing Market Segment Percentages, by Application, 2023 (%)
Hospitals
Diagnostic Laboratories
Others
Global Respiratory Syncytial Virus Diagnostic Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Respiratory Syncytial Virus Diagnostic Testing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Respiratory Syncytial Virus Diagnostic Testing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Respiratory Syncytial Virus Diagnostic Testing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche AG
Abbott
Thermo Fisher Scientific
BD (Becton, Dickinson and Company)
QuidelOrtho Corporation
Hologic, Inc.
Luminex Corporation
Agilent Technologies, Inc.
Cepheid (Danaher Corporation)
DiaSorin S.p.A.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Respiratory Syncytial Virus Diagnostic Testing, market overview.
Chapter 2: Global Respiratory Syncytial Virus Diagnostic Testing market size in revenue.
Chapter 3: Detailed analysis of Respiratory Syncytial Virus Diagnostic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Respiratory Syncytial Virus Diagnostic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Respiratory Syncytial Virus Diagnostic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Syncytial Virus Diagnostic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Syncytial Virus Diagnostic Testing Overall Market Size
2.1 Global Respiratory Syncytial Virus Diagnostic Testing Market Size: 2023 VS 2030
2.2 Global Respiratory Syncytial Virus Diagnostic Testing Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Syncytial Virus Diagnostic Testing Players in Global Market
3.2 Top Global Respiratory Syncytial Virus Diagnostic Testing Companies Ranked by Revenue
3.3 Global Respiratory Syncytial Virus Diagnostic Testing Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Syncytial Virus Diagnostic Testing Companies in Global Market, by Revenue in 2023
3.5 Global Companies Respiratory Syncytial Virus Diagnostic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Syncytial Virus Diagnostic Testing Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Syncytial Virus Diagnostic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus Diagnostic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Respiratory Syncytial Virus Diagnostic Testing Market Size Markets, 2023 & 2030
4.1.2 Antigen Detection Test
4.1.3 Molecular Diagnostic Test
4.1.4 Direct Fluorescent Antibody Test
4.1.5 Diagnostic Imaging
4.1.6 Others
4.2 By Type - Global Respiratory Syncytial Virus Diagnostic Testing Revenue & Forecasts
4.2.1 By Type - Global Respiratory Syncytial Virus Diagnostic Testing Revenue, 2019-2024
4.2.2 By Type - Global Respiratory Syncytial Virus Diagnostic Testing Revenue, 2025-2030
4.2.3 By Type - Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory Syncytial Virus Diagnostic Testing Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Others
5.2 By Application - Global Respiratory Syncytial Virus Diagnostic Testing Revenue & Forecasts
5.2.1 By Application - Global Respiratory Syncytial Virus Diagnostic Testing Revenue, 2019-2024
5.2.2 By Application - Global Respiratory Syncytial Virus Diagnostic Testing Revenue, 2025-2030
5.2.3 By Application - Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Respiratory Syncytial Virus Diagnostic Testing Market Size, 2023 & 2030
6.2 By Region - Global Respiratory Syncytial Virus Diagnostic Testing Revenue & Forecasts
6.2.1 By Region - Global Respiratory Syncytial Virus Diagnostic Testing Revenue, 2019-2024
6.2.2 By Region - Global Respiratory Syncytial Virus Diagnostic Testing Revenue, 2025-2030
6.2.3 By Region - Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Respiratory Syncytial Virus Diagnostic Testing Revenue, 2019-2030
6.3.2 US Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.3.3 Canada Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.3.4 Mexico Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Respiratory Syncytial Virus Diagnostic Testing Revenue, 2019-2030
6.4.2 Germany Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.4.3 France Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.4.4 U.K. Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.4.5 Italy Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.4.6 Russia Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.4.7 Nordic Countries Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.4.8 Benelux Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Respiratory Syncytial Virus Diagnostic Testing Revenue, 2019-2030
6.5.2 China Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.5.3 Japan Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.5.4 South Korea Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.5.5 Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.5.6 India Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Respiratory Syncytial Virus Diagnostic Testing Revenue, 2019-2030
6.6.2 Brazil Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.6.3 Argentina Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Revenue, 2019-2030
6.7.2 Turkey Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.7.3 Israel Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.7.4 Saudi Arabia Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
6.7.5 UAE Respiratory Syncytial Virus Diagnostic Testing Market Size, 2019-2030
7 Respiratory Syncytial Virus Diagnostic Testing Companies Profiles
7.1 F. Hoffmann-La Roche AG
7.1.1 F. Hoffmann-La Roche AG Company Summary
7.1.2 F. Hoffmann-La Roche AG Business Overview
7.1.3 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Major Product Offerings
7.1.4 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Revenue in Global Market (2019-2024)
7.1.5 F. Hoffmann-La Roche AG Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Respiratory Syncytial Virus Diagnostic Testing Major Product Offerings
7.2.4 Abbott Respiratory Syncytial Virus Diagnostic Testing Revenue in Global Market (2019-2024)
7.2.5 Abbott Key News & Latest Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Major Product Offerings
7.3.4 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Revenue in Global Market (2019-2024)
7.3.5 Thermo Fisher Scientific Key News & Latest Developments
7.4 BD (Becton, Dickinson and Company)
7.4.1 BD (Becton, Dickinson and Company) Company Summary
7.4.2 BD (Becton, Dickinson and Company) Business Overview
7.4.3 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Major Product Offerings
7.4.4 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Revenue in Global Market (2019-2024)
7.4.5 BD (Becton, Dickinson and Company) Key News & Latest Developments
7.5 QuidelOrtho Corporation
7.5.1 QuidelOrtho Corporation Company Summary
7.5.2 QuidelOrtho Corporation Business Overview
7.5.3 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Major Product Offerings
7.5.4 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue in Global Market (2019-2024)
7.5.5 QuidelOrtho Corporation Key News & Latest Developments
7.6 Hologic, Inc.
7.6.1 Hologic, Inc. Company Summary
7.6.2 Hologic, Inc. Business Overview
7.6.3 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Major Product Offerings
7.6.4 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue in Global Market (2019-2024)
7.6.5 Hologic, Inc. Key News & Latest Developments
7.7 Luminex Corporation
7.7.1 Luminex Corporation Company Summary
7.7.2 Luminex Corporation Business Overview
7.7.3 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Major Product Offerings
7.7.4 Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue in Global Market (2019-2024)
7.7.5 Luminex Corporation Key News & Latest Developments
7.8 Agilent Technologies, Inc.
7.8.1 Agilent Technologies, Inc. Company Summary
7.8.2 Agilent Technologies, Inc. Business Overview
7.8.3 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Major Product Offerings
7.8.4 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue in Global Market (2019-2024)
7.8.5 Agilent Technologies, Inc. Key News & Latest Developments
7.9 Cepheid (Danaher Corporation)
7.9.1 Cepheid (Danaher Corporation) Company Summary
7.9.2 Cepheid (Danaher Corporation) Business Overview
7.9.3 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Major Product Offerings
7.9.4 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Revenue in Global Market (2019-2024)
7.9.5 Cepheid (Danaher Corporation) Key News & Latest Developments
7.10 DiaSorin S.p.A.
7.10.1 DiaSorin S.p.A. Company Summary
7.10.2 DiaSorin S.p.A. Business Overview
7.10.3 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Major Product Offerings
7.10.4 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Revenue in Global Market (2019-2024)
7.10.5 DiaSorin S.p.A. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Respiratory Syncytial Virus Diagnostic Testing Market Opportunities & Trends in Global Market
Table 2. Respiratory Syncytial Virus Diagnostic Testing Market Drivers in Global Market
Table 3. Respiratory Syncytial Virus Diagnostic Testing Market Restraints in Global Market
Table 4. Key Players of Respiratory Syncytial Virus Diagnostic Testing in Global Market
Table 5. Top Respiratory Syncytial Virus Diagnostic Testing Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Respiratory Syncytial Virus Diagnostic Testing Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Respiratory Syncytial Virus Diagnostic Testing Revenue Share by Companies, 2019-2024
Table 8. Global Companies Respiratory Syncytial Virus Diagnostic Testing Product Type
Table 9. List of Global Tier 1 Respiratory Syncytial Virus Diagnostic Testing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus Diagnostic Testing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Respiratory Syncytial Virus Diagnostic Testing Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Respiratory Syncytial Virus Diagnostic Testing Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Respiratory Syncytial Virus Diagnostic Testing Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Respiratory Syncytial Virus Diagnostic Testing Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2025-2030
Table 30. F. Hoffmann-La Roche AG Company Summary
Table 31. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Product Offerings
Table 32. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn) & (2019-2024)
Table 33. F. Hoffmann-La Roche AG Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Respiratory Syncytial Virus Diagnostic Testing Product Offerings
Table 36. Abbott Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn) & (2019-2024)
Table 37. Abbott Key News & Latest Developments
Table 38. Thermo Fisher Scientific Company Summary
Table 39. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Product Offerings
Table 40. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn) & (2019-2024)
Table 41. Thermo Fisher Scientific Key News & Latest Developments
Table 42. BD (Becton, Dickinson and Company) Company Summary
Table 43. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Product Offerings
Table 44. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn) & (2019-2024)
Table 45. BD (Becton, Dickinson and Company) Key News & Latest Developments
Table 46. QuidelOrtho Corporation Company Summary
Table 47. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Product Offerings
Table 48. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn) & (2019-2024)
Table 49. QuidelOrtho Corporation Key News & Latest Developments
Table 50. Hologic, Inc. Company Summary
Table 51. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Product Offerings
Table 52. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn) & (2019-2024)
Table 53. Hologic, Inc. Key News & Latest Developments
Table 54. Luminex Corporation Company Summary
Table 55. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Product Offerings
Table 56. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn) & (2019-2024)
Table 57. Luminex Corporation Key News & Latest Developments
Table 58. Agilent Technologies, Inc. Company Summary
Table 59. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Product Offerings
Table 60. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn) & (2019-2024)
Table 61. Agilent Technologies, Inc. Key News & Latest Developments
Table 62. Cepheid (Danaher Corporation) Company Summary
Table 63. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Product Offerings
Table 64. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn) & (2019-2024)
Table 65. Cepheid (Danaher Corporation) Key News & Latest Developments
Table 66. DiaSorin S.p.A. Company Summary
Table 67. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Product Offerings
Table 68. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Revenue (US$, Mn) & (2019-2024)
Table 69. DiaSorin S.p.A. Key News & Latest Developments
List of Figures
Figure 1. Respiratory Syncytial Virus Diagnostic Testing Segment by Type in 2023
Figure 2. Respiratory Syncytial Virus Diagnostic Testing Segment by Application in 2023
Figure 3. Global Respiratory Syncytial Virus Diagnostic Testing Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Respiratory Syncytial Virus Diagnostic Testing Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Respiratory Syncytial Virus Diagnostic Testing Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Syncytial Virus Diagnostic Testing Revenue in 2023
Figure 8. By Type - Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
Figure 9. By Application - Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
Figure 10. By Type - Global Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
Figure 12. By Application - Global Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
Figure 14. By Region - Global Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
Figure 15. By Country - North America Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
Figure 16. US Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
Figure 20. Germany Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 21. France Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
Figure 28. China Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 32. India Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
Figure 34. Brazil Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Respiratory Syncytial Virus Diagnostic Testing Revenue Market Share, 2019-2030
Figure 37. Turkey Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Respiratory Syncytial Virus Diagnostic Testing Revenue, (US$, Mn), 2019-2030
Figure 41. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Abbott Respiratory Syncytial Virus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Luminex Corporation Respiratory Syncytial Virus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
